¹Table 1.

Conventional and Atypical disease incidence in WT and IFNγRKO recipients of 5×10⁶ Th1-polarized MOG_35–55-reactive CD4 T cells

	EAE Incidence	Disease Phenotype	Incidence
WT	44/47 (93%)	Pure Conventional	31/44 (71%)
		Pure Atypical	4/44 (9%)
		Mixed	9/44 (20%)
IFNγRKO	38/48 (79%)	Pure Conventional	4/38 (10%)
		Pure Atypical	24/38 (63%)
		Mixed	10/38 (27%)

¹5×10⁶ MOG_35–55-reactive, Th1-polarized CD4 T cells were purified and transferred into WT and IFNγRKO recipients (as described in the materials and methods). Data were pooled from at least 6 experiments.